Could a tiny radiation dose tame this rare skin cancer?
NCT ID NCT07310745
First seen Jan 02, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This study looks at whether a very low dose of radiation (4 Gy) can effectively control a rare, slow-growing type of skin lymphoma called primary indolent cutaneous B-cell lymphoma. Researchers reviewed records of 52 adults who received this treatment to see how long the cancer stayed away and what side effects occurred. The goal is to find a gentler treatment option that still works well.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY INDOLENT CUTANEOUS B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda USL IRCCS di Reggio Emilia - Sc Radioterapia
Reggio Emilia, Italy
Conditions
Explore the condition pages connected to this study.